Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[50] Reaction with N-carboxy-α-amino acid anhydrides.

Methods in enzymology·2012
Same author

A non-invasive model for measuring nociception after tooth pulp exposure.

Journal of dental research·2012
Same author

Reduced GABA(A) receptor α6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity.

Neuroscience·2012
Same author

Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.

Clinical transplantation·2011
Same author

Stevens-Johnson syndrome after Mycoplasma pneumonia infection in pediatric post-liver transplant recipient: case report and review of the literature.

Pediatric transplantation·2010
Same author

Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.

Medical hypotheses·2010

相关实验视频

Updated: Jul 13, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

通过对抗原-Ia复合体的抗体对实验性过敏性脑膜炎的免疫调节.

R Aharoni1, D Teitelbaum, R Arnon

  • 1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Nature
|May 9, 1991
PubMed
概括

用抗体向特定的自身抗原和MHC分子复合体,为自身免疫性疾病 (如实验性过敏性脑膜炎) 提供了一种新的治疗方法. 这种方法可以选择性地阻止有害的T细胞反应,而不会影响有益的免疫功能.

科学领域:

  • 免疫学 免疫学 免疫学
  • 自免疫性疾病 自免疫性疾病
  • 神经免疫学 神经免疫学

背景情况:

  • 自身免疫性疾病涉及T淋巴细胞错误地识别由MHCII类分子呈现的自我抗原.
  • 目前针对抗原-MHC-TCR复合物的单个成分的治疗方法可能会导致非目标免疫效应.
  • 实验性过敏性脑膜炎 (EAE) 是由CD4+T细胞介导的自身免疫疾病的一个模型.

研究的目的:

  • 开发和测试一种针对特定的自身抗原-MHC复合体的新型治疗策略.
  • 在自身免疫性疾病模型中,研究专门与自身抗原-MHC复合体结合的抗体的疗效.

主要方法:

  • 产生针对髓基蛋白 (BP) 复合体和自我IA的单克隆抗体.
  • 在体外评估抗体对T细胞增殖的作用,以应对BP和对照抗原.
  • 在H-2s小鼠实验性过敏脑炎 (EAE) 抑制抗体功效的体内测试.

主要成果:

  • 单克隆抗体特别识别了BP和IA复合体.
  • 这些抗体在体外阻断了T细胞对脑原性BP决定因子的增殖,并降低了对完整BP的反应.
  • 抗体治疗在小鼠中显著抑制了EAE的发展,而不会影响对非相关抗原的反应.

更多相关视频

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

相关实验视频

Last Updated: Jul 13, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

结论:

  • 针对独特的自身抗原-MHC复合体的抗体提供一种高度选择性的阻断病原性T细胞反应.
  • 这一战略表明了对自身免疫性疾病的有效和特定治疗的潜力.
  • 准三分子复合体为自身免疫性疾病治疗提供了一个有前途的途径.